TANGO THERAPEUTICS, INC.

(TNGX)
  Report
Delayed Nasdaq  -  04:00 2022-06-24 pm EDT
4.630 USD   +9.46%
06/23TANGO THERAPEUTICS : Corporate Presentation
PU
06/10TANGO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/08Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Conference
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Edging Lower Ahead of Wednesday Close

05/11/2022 | 03:58pm EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
BLIRT S.A. 2.05% 14.9 End-of-day quote.75.50%
NASDAQ COMPOSITE 3.34% 11607.62 Real-time Quote.-28.21%
NOVAVAX, INC. -0.27% 51.67 Delayed Quote.-63.88%
QIAGEN N.V. 4.02% 46.63 Delayed Quote.-16.10%
REGULUS THERAPEUTICS INC. -7.50% 0.2406 Delayed Quote.-23.62%
TANGO THERAPEUTICS, INC. 9.46% 4.63 Delayed Quote.-57.68%
All news about TANGO THERAPEUTICS, INC.
06/23TANGO THERAPEUTICS : Corporate Presentation
PU
06/10TANGO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/08Tango Therapeutics to Participate in the Goldman Sachs 43rd Annual Global Healthcare Co..
AQ
05/20TANGO THERAPEUTICS : Corporate Presentation
PU
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
MT
05/11SECTOR UPDATE : Health Care
MT
05/11Tango Therapeutics Posts Q1 Loss, Revenue Falls
MT
05/11TANGO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition a..
AQ
05/11Tango Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31,..
CI
05/11Tango Therapeutics Reports First Quarter 2022 Financial Results and Provides Business H..
AQ
More news
Analyst Recommendations on TANGO THERAPEUTICS, INC.
More recommendations
Financials (USD)
Sales 2022 22,3 M - -
Net income 2022 -117 M - -
Net cash 2022 108 M - -
P/E ratio 2022 -3,51x
Yield 2022 -
Capitalization 407 M 407 M -
EV / Sales 2022 13,4x
EV / Sales 2023 12,9x
Nbr of Employees 98
Free-Float 84,7%
Chart TANGO THERAPEUTICS, INC.
Duration : Period :
Tango Therapeutics, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TANGO THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 4,63 $
Average target price 15,40 $
Spread / Average Target 233%
EPS Revisions
Managers and Directors
Barbara L. Weber President, Chief Executive Officer & Director
Daniella Beckman Chief Financial Officer
Lesley Ann Calhoun Chairman
Alan Huang Chief Scientific Officer
Marc S. Rudoltz Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
TANGO THERAPEUTICS, INC.-57.68%407
MODERNA, INC.-43.20%57 385
IQVIA HOLDINGS INC.-24.22%40 468
LONZA GROUP AG-32.67%39 851
SEAGEN INC.16.00%33 010
CELLTRION, INC.-13.38%18 371